Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2000 TO 2099]"
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Medical Condition: cHL in children and young adults MedDRA version: 20.1Level: LLTClassification code 10080208Term: Classical Hodgkin lymphomaSystem Organ Class: 100000004864;Therapeutic area: Diseases [C] - Cancer [C04]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+cHL+in+children+and+young+adults+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10080208Term%3A+Classical+Hodgkin+lymphomaSystem+Organ+Class%3A+100000004864%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Young+Adult%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+cHL+in+children+and+young+adults+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10080208Term%3A+Classical+Hodgkin+lymphomaSystem+Organ+Class%3A+100000004864%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Young+Adult%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+cHL+in+children+and+young+adults+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10080208Term%3A+Classical+Hodgkin+lymphomaSystem+Organ+Class%3A+100000004864%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Young+Adult%22&type=Subject
PubPharm (10)
1
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667). - A phase 2 trial of MK-3475 in participants with Hodgkin Lymphoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma : An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667). - A phase 2 trial of MK-3475 in participants with Hodgkin Lymphoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2000-2099
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Medical Condition: cHL in children and young adults MedDRA version: 20.1Level: LLTClassification code 10080208Term: Classical Hodgkin lymphomaSystem Organ Class: 100000004864;Therapeutic area: Diseases [C] - Cancer [C04]
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
10
610
Medical Condition: cHL in children and young ad...
10
Phase: Phase 2
10
Recruitment Status: Authorised-recruitment may ...
10
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2000-
8
2021
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...